Rossari Biotech Limited (BOM:543213)
635.40
+7.80 (1.24%)
At close: Sep 3, 2025
Rossari Biotech Revenue
Rossari Biotech had revenue of 5.44B INR in the quarter ending June 30, 2025, with 11.04% growth. This brings the company's revenue in the last twelve months to 21.34B, up 11.77% year-over-year. In the fiscal year ending March 31, 2025, Rossari Biotech had annual revenue of 20.80B with 13.64% growth.
Revenue (ttm)
21.34B
Revenue Growth
+11.77%
P/S Ratio
1.63
Revenue / Employee
39.89M
Employees
535
Market Cap
34.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 20.80B | 2.50B | 13.64% |
Mar 31, 2024 | 18.31B | 1.75B | 10.55% |
Mar 31, 2023 | 16.56B | 1.73B | 11.66% |
Mar 31, 2022 | 14.83B | 7.74B | 109.06% |
Mar 31, 2021 | 7.09B | 1.09B | 18.21% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,839.41B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,503.84B |
Hindustan Unilever | 639.28B |
Infosys | 1,672.76B |